• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌微血管侵犯的分类:与预后和磁共振成像的相关性。

Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging.

机构信息

Departments of Pathology Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Departments of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2023 Jul;29(3):733-746. doi: 10.3350/cmh.2023.0034. Epub 2023 May 8.

DOI:10.3350/cmh.2023.0034
PMID:37157775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10366800/
Abstract

BACKGROUND/AIMS: The microvascular invasion (MVI) of hepatocellular carcinoma (HCC) involves a wide histological spectrum, and it is unclear whether the degree of MVI correlates with patient prognosis or imaging findings. Here, we evaluate the prognostic value of MVI classification and analyze the radiologic features predictive of MVI.

METHODS

Using a retrospective cohort of 506 patients with resected solitary HCCs, the histological and imaging features of MVI were reviewed and correlated with clinical data.

RESULTS

MVI-positive HCCs invading ≥5 vessels or those with ≥50 invaded tumor cells were significantly associated with decreased overall survival (OS). The 5-year OS, recurrence-free survival (RFS), and beyond Milan criteria RFS rates were significantly poorer in patients with severe MVI compared with those with mild or no MVI. Severe MVI was a significant independent predictive factor for OS (odds ratio [OR], 2.962; p<0.001), RFS (OR, 1.638; p=0.002), and beyond Milan criteria RFS (OR, 2.797; p<0.001) on multivariable analysis. On MRI, non-smooth tumor margins (OR, 2.224; p=0.023) and satellite nodules (OR, 3.264; p<0.001) were independently associated with the severe-MVI group on multivariable analysis. Both non-smooth tumor margins and satellite nodules were associated with worse 5-year OS, RFS, and beyond Milan criteria RFS.

CONCLUSION

Histologic risk classification of MVI according to the number of invaded microvessels and invading carcinoma cells was a valuable predictor of prognosis in HCC patients. Non-smooth tumor margin and satellite nodules were significantly associated with severe MVI and poor prognosis.

摘要

背景/目的:肝细胞癌(HCC)的微血管侵犯(MVI)涉及广泛的组织学谱,并且尚不清楚 MVI 的程度是否与患者预后或影像学表现相关。在这里,我们评估 MVI 分类的预后价值,并分析预测 MVI 的影像学特征。

方法

使用 506 例接受根治性单发 HCC 切除术患者的回顾性队列,回顾性分析 MVI 的组织学和影像学特征,并与临床数据相关联。

结果

侵犯≥5 支血管或≥50 个侵袭性肿瘤细胞的 MVI 阳性 HCC 患者的总生存期(OS)明显降低。与轻度或无 MVI 的患者相比,严重 MVI 的患者 5 年 OS、无复发生存率(RFS)和超过米兰标准的 RFS 率明显较差。严重 MVI 是 OS(优势比 [OR],2.962;p<0.001)、RFS(OR,1.638;p=0.002)和超过米兰标准的 RFS(OR,2.797;p<0.001)的独立预测因素。在 MRI 上,非平滑肿瘤边缘(OR,2.224;p=0.023)和卫星结节(OR,3.264;p<0.001)在多变量分析中与严重-MVI 组独立相关。非平滑肿瘤边缘和卫星结节均与较差的 5 年 OS、RFS 和超过米兰标准的 RFS 相关。

结论

根据侵犯微血管的数量和侵袭性癌细胞对 MVI 进行组织学风险分类是 HCC 患者预后的有价值的预测指标。非平滑肿瘤边缘和卫星结节与严重 MVI 和不良预后显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/137988407760/cmh-2023-0034f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/734a3703454d/cmh-2023-0034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/c9b22796095c/cmh-2023-0034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/6a3de08f0458/cmh-2023-0034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/664e630b6579/cmh-2023-0034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/29317e6c27c8/cmh-2023-0034f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/137988407760/cmh-2023-0034f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/734a3703454d/cmh-2023-0034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/c9b22796095c/cmh-2023-0034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/6a3de08f0458/cmh-2023-0034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/664e630b6579/cmh-2023-0034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/29317e6c27c8/cmh-2023-0034f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/653e/10366800/137988407760/cmh-2023-0034f6.jpg

相似文献

1
Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging.肝细胞癌微血管侵犯的分类:与预后和磁共振成像的相关性。
Clin Mol Hepatol. 2023 Jul;29(3):733-746. doi: 10.3350/cmh.2023.0034. Epub 2023 May 8.
2
Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.使用钆塞酸增强 MRI 对米兰标准内单个肝细胞癌进行术前微血管侵犯风险评估,以预测肝移植术后的结局。
Eur Radiol. 2024 Jan;34(1):498-508. doi: 10.1007/s00330-023-09936-y. Epub 2023 Jul 28.
3
Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.切除术后肝细胞癌患者微血管侵犯新风险分类的预后价值
Oncotarget. 2017 Jan 17;8(3):5474-5486. doi: 10.18632/oncotarget.12547.
4
Prognostic factors for long-term outcome in bifocal hepatocellular carcinoma after resection.双焦点肝细胞癌切除术后长期预后的预测因素。
Eur Radiol. 2023 May;33(5):3604-3616. doi: 10.1007/s00330-023-09398-2. Epub 2023 Jan 26.
5
Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.钆塞酸二钠增强 MRI 的多尺度多参数放射组学预测≤5cm 单发肝细胞癌的微血管侵犯和预后。
Eur Radiol. 2021 Jul;31(7):4824-4838. doi: 10.1007/s00330-020-07601-2. Epub 2021 Jan 14.
6
Preoperative Gadoxetic Acid-Enhanced MRI Features for Evaluation of Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma: Creating Nomograms for Risk Assessment.术前钆塞酸增强 MRI 特征评估肝癌肿瘤簇包绕血管和微血管侵犯:创建风险评估列线图。
J Magn Reson Imaging. 2024 Sep;60(3):1094-1110. doi: 10.1002/jmri.29187. Epub 2023 Dec 20.
7
Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters.无微血管侵犯的单发肝细胞癌 ≤ 5cm 的风险分层:基于 LI-RADS 和临床参数的 MRI 特征的预后价值。
Eur Radiol. 2023 May;33(5):3592-3603. doi: 10.1007/s00330-023-09484-5. Epub 2023 Mar 8.
8
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.基于动态对比增强 MRI 联合临床参数的深度学习预测肝细胞癌微血管侵犯
J Cancer Res Clin Oncol. 2021 Dec;147(12):3757-3767. doi: 10.1007/s00432-021-03617-3. Epub 2021 Apr 10.
9
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.肝细胞癌合并微血管侵犯患者的术后辅助治疗策略:一项非随机介入性临床研究。
BMC Cancer. 2020 Jul 1;20(1):614. doi: 10.1186/s12885-020-07087-7.
10
New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.肝细胞癌微血管侵犯的新病理分层:预测活体肝移植后的预后
Transplantation. 2015 Jun;99(6):1236-42. doi: 10.1097/TP.0000000000000489.

引用本文的文献

1
Letter to "Preoperative Prediction of Microvascular Invasion by EOB-MRI Imaging for Surgical Decision".致《基于EOB-MRI成像术前预测微血管侵犯以指导手术决策》的信
Liver Cancer. 2024 Oct 17;14(3):351-352. doi: 10.1159/000541884. eCollection 2025 Jun.
2
MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma.用于肝细胞癌预后评估的MRI成像生物标志物
J Korean Soc Radiol. 2025 May;86(3):364-380. doi: 10.3348/jksr.2025.0029. Epub 2025 May 28.
3
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).

本文引用的文献

1
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.《2022年韩国肝脏癌协会-韩国国立癌症中心肝细胞癌管理实践指南》
J Liver Cancer. 2023 Mar;23(1):1-120. doi: 10.17998/jlc.2022.11.07. Epub 2022 Dec 9.
2
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.2022 KLCA-NCC 韩国肝细胞癌管理实践指南。
Clin Mol Hepatol. 2022 Oct;28(4):583-705. doi: 10.3350/cmh.2022.0294. Epub 2022 Oct 1.
3
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review.
肝细胞癌微血管侵犯诊断与治疗中国专家共识(2024年版)
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30.
4
Evaluating the severity of microvascular invasion in hepatocellular carcinoma, by probing the combination of enhancement modes and growth patterns through magnetic resonance imaging.通过磁共振成像探究增强模式与生长方式的组合,评估肝细胞癌微血管侵犯的严重程度。
Radiol Oncol. 2025 Apr 11;59(2):183-192. doi: 10.2478/raon-2025-0021. eCollection 2025 Jun 1.
5
Gd-EOB-DTPA-enhanced MRI radiomics and deep learning models to predict microvascular invasion in hepatocellular carcinoma: a multicenter study.钆塞酸二钠增强磁共振成像的影像组学和深度学习模型预测肝细胞癌微血管侵犯:一项多中心研究
BMC Med Imaging. 2025 Mar 31;25(1):105. doi: 10.1186/s12880-025-01646-9.
6
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma.病毒复制活性与乙型肝炎病毒相关肝细胞癌术后复发之间的关联
Aliment Pharmacol Ther. 2025 May;61(10):1680-1691. doi: 10.1111/apt.70085. Epub 2025 Mar 16.
7
A novel nomogram based on complement C3 to predict the overall survival of early-stage hepatocellular carcinoma patients with microvascular invasion-positive undergoing curative resection.一种基于补体C3的新型列线图,用于预测接受根治性切除的微血管侵犯阳性早期肝细胞癌患者的总生存期。
Front Oncol. 2025 Feb 20;15:1559083. doi: 10.3389/fonc.2025.1559083. eCollection 2025.
8
Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing.基于空间转录组测序的微血管侵犯特征基因构建肝细胞癌预后模型
Front Immunol. 2025 Feb 20;16:1529569. doi: 10.3389/fimmu.2025.1529569. eCollection 2025.
9
Predicting microvascular invasion in solitary hepatocellular carcinoma: a multi-center study integrating clinical, MRI assessments, and radiomics indicators.预测孤立性肝细胞癌中的微血管侵犯:一项整合临床、MRI评估和影像组学指标的多中心研究
Front Oncol. 2025 Feb 19;15:1511260. doi: 10.3389/fonc.2025.1511260. eCollection 2025.
10
Histone lactylation drives liver cancer metastasis by facilitating NSF1-mediated ferroptosis resistance after microwave ablation.组蛋白乳酰化通过促进微波消融后NSF1介导的铁死亡抗性来驱动肝癌转移。
Redox Biol. 2025 Apr;81:103553. doi: 10.1016/j.redox.2025.103553. Epub 2025 Feb 15.
肝癌肝移植术后复发的预测模型:全面综述。
Clin Mol Hepatol. 2022 Oct;28(4):739-753. doi: 10.3350/cmh.2022.0060. Epub 2022 Apr 26.
4
Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.钆塞酸增强 MRI 预测肝细胞癌微血管侵犯的观察者间变异性和诊断性能。
Radiology. 2020 Dec;297(3):573-581. doi: 10.1148/radiol.2020201940. Epub 2020 Sep 29.
5
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients.即使在早期肝细胞癌患者无复发 5 年后,仍存在复发的重大风险。
Clin Mol Hepatol. 2020 Oct;26(4):516-528. doi: 10.3350/cmh.2020.0016. Epub 2020 Sep 11.
6
Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiology, and End-Results Database.微血管侵犯和2 cm的大小临界值可预测多发性肝细胞癌的长期肿瘤学结局:对美国癌症联合委员会分期系统的重新评估及使用监测、流行病学和最终结果数据库进行验证
Liver Cancer. 2020 Apr;9(2):156-166. doi: 10.1159/000504193. Epub 2019 Dec 11.
7
Subclassification of Microscopic Vascular Invasion in Hepatocellular Carcinoma.肝细胞癌的微血管侵犯的亚分类。
Ann Surg. 2021 Dec 1;274(6):e1170-e1178. doi: 10.1097/SLA.0000000000003781.
8
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.射频消融作为潜在可移植患者小于 3cm 的肝细胞癌一线治疗的结果。
J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.
9
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.巨梁型-块状肝细胞癌:一种具有临床相关性的独特组织学亚型。
Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.
10
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.米兰标准以外的肝细胞癌切除术后复发预测:一项国际队列临床风险评分的验证
Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.